The impact of COVID-19 on hepatitis elimination.

Wingrove, Chris; Ferrier, Lucy; James, Cary; Wang, Su

Wingrove, Chris; Ferrier, Lucy; James, Cary; Wang, Su.

Wingrove C; World Hepatitis Alliance, London SE1 3YD, UK. Electronic address: chris.wingrove@worldhepatitisalliance.org.
Ferrier L; World Hepatitis Alliance, London SE1 3YD, UK.
James C; World Hepatitis Alliance, London SE1 3YD, UK.
Wang S; World Hepatitis Alliance, London SE1 3YD, UK; Center for Asian Health, Florham Park, NJ, USA; Hepatitis B Foundation, Doylestown, PA, USA.

Lancet Gastroenterol Hepatol ; 5(9): 792-794, 2020 09.

Article in English | MEDLINE | ID: covidwho-676867

Subject(s)

Coronavirus Infections/epidemiology; Disease Eradication; Health Services Accessibility; Hepatitis, Viral, Human/prevention & control; Pneumonia, Viral/epidemiology; Antiviral Agents/therapeutic use; Betacoronavirus; COVID-19; Hepatitis, Viral, Human/drug therapy; Humans; Pandemics; SARS-CoV-2

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Coronavirus Infections / Disease Eradication / Health Services Accessibility / Hepatitis, Viral, Human Type of study: Experimental Studies / Observational study Limits: Humans Language: English Journal: Lancet Gastroenterol Hepatol Year: 2020 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google